Protein-coding content of the sequence of Marek's disease virus serotype 1

Current Topics in Microbiology and Immunology

Volumn 255, Issue , 2000, Pages 159-190

  Lupiani, B ^a   Lee, L F ^a   Reddy, S M ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; GLYCOPROTEIN GB; GLYCOPROTEIN GC; GLYCOPROTEIN GD; GLYCOPROTEIN GH; GLYCOPROTEIN GI; GLYCOPROTEIN GK; GLYCOPROTEIN GL; GLYCOPROTEIN GP82; INTERLEUKIN 8; NUCLEOCAPSID PROTEIN; ORIGIN BINDING PROTEIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PP14; PHOSPHOPROTEIN PP24; PHOSPHOPROTEIN PP38; PROTEIN ICP27; PROTEIN ICP4; PROTEIN KINASE; PROTEIN KINASE UL13; PROTEIN KINASE US3; PROTEIN MEQ; PROTEIN SORF2; PROTEIN UL47; PROTEIN UL49; PROTEIN VP16; RIBONUCLEOTIDE REDUCTASE; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN;

AVIAN LYMPHOMATOSIS HERPETOVIRUS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SEROTYPE; TRANSCRIPTION REGULATION; VIRUS GENOME;

GENES, REGULATOR; GLYCOPROTEINS; HERPESVIRUS 2, GALLID; MOLECULAR WEIGHT; OPEN READING FRAMES; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

AVES; GALLID HERPESVIRUS 2; HERPETOVIRUS; MARDIVIRUS;

EID: 0034537208     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (115)

1. Complete nuclcotide sequence of the Marek's disease virus ICP4 gene
2. The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus
3. Lipase activities of p37, the major envelope protein of vaccinia virus
4. A general structure for DNA-dependent DNA polymerases
5. Marek's disease virus UL48 (VP16) contains multiple functional domains and transactivates both homologous and heterologous immediate early gene promoters
6. Structure of the Marek's disease virus BamHI-H gene family: Genes of putative importance for tumor induction
7. Analysis of Marek's disease virus glycoproteins D, I and E.
8. The Marek's disease virus (MDV) unique short region: Alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes
9. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: Implications for herpesvirus classification
10. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target
11. Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen
12. Precipitating antibodies associated with Marek's disease
13. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture
14. Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2
15. Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro
16. Herpes simplex-1 DNA polymerase. Identification of an intrinsic 5′-3′ exonuclease with ribonuclease H activity
17. Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells
18. Construction and characterization of a H19 epitope point mutant of MDV CVI988/rispens strain
19. Establishment of a lymphoblastoid cell line using a mutant MDV containing a green fluorescent protein expression cassette
20. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells
21. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides
22. Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge
23. Enhancement of gene expression by Marek's disease virus homologue of the herpes simplex virus-1 ICP4
24. Locating a nucleotide binding site in the thymidine kinase of vaccinia virus and of herpes simplex virus by scoring triply aligned protein sequences
25. Structure-function studies of the herpes simplex virus type 1 DNA polymerase
26. Role of glycoprotein gD in the adhesion of pseudorabies virus infected cells and subsequent cell-associated virus spread
27. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro
28. Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide
29. A 14-kDa immediate-early phosphoprotein is specifically expressed in cells infected with oncogenic Marek's disease virus strains and their attenuated derivatives
30. Monoclonal antibodies reactive with the surface and secreted glycoproteins of Marek's disease virus and herpesvirus of turkeys
31. Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization
32. Retrovirus insertion into herpesvirus in vitro and in vivo
33. Integration of multiple chicken retroviruses into multiple chicken herpesviruses: Herpesviral gD as a common target of integration
34. Molecular characterization of Marek's disease herpesvirus B antigen
35. Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein
36. Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin
37. Marek's disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors
38. DNA polymerase I: From crystal structure to function via genetics
39. Investigations on the mode of transmission of the herpesvirus of turkeys in vitro
40. Thymidine kinase
41. The nucleotide sequence of the chicken thymidine kinase gene and the relationship of its predicted polypeptide to that of the vaccinia virus thymidine kinase
42. Viral aspects of protein phosphorylation
43. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens
44. Effect of phosphonoacetate on Marek's disease virus replication
45. Identification and transcriptional analysis of Marek's disease virus gene encoding membrane glycoprotein gp82
46. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus
47. Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion
48. Use of recombinant pp38 antigen of Marek's disease virus to identify scrotype 1-specific antibodies in chicken sera by western blotting
49. Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ
50. MEQ and V-IL8: Cellular genes in disguise?
51. Transforming potential of the herpesvirus oncoprotein MEQ: Morphological transformation, serum-independent growth, and inhibition of apoptosis
52. EBV induces the production and release of IL-8 and macrophage inflammatory protein-1 alpha in human neutrophils
53. Characterization of Marek's disease virus RB1B-based mutants having disrupted glycoprotein C or glycoprotein D homolog genes
54. The Marek's disease virus ICP4 gene: Update on sense and antisense RNAs and characterization of the gene product
55. Varicella-zoster virus open reading frame 10 protein, the herpes simplex vires VP16 homolog, transactivates herpesvirus immediate-early gene promoters
56. Analysis of Marek's disease virus serotype 1-specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells
57. Selective inhibition by phosphonoacetic acid of MDV DNA replication in a lymphoblastoid cell line
58. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus
59. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus
60. MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens
61. Structural features of ribonucleotide reductase
62. Detection of Marek's disease virus serotype 1 (MDV1) glycoprotein D in MDV1-infected chick embryo fibroblasts
63. Nucleotide sequence of the marmoset herpesvirus thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide
64. Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames
65. Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes
66. Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV
67. Enhanced expression of the Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homologue of ICP4
68. Responses of cell cultures from various avian species to Marek's disease virus and herpesvirus of turkeys
69. Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells
70. Identification and structural analysis of a MDV gene encoding a protein kinase
71. Identification and characterization of a Marek's disease virus gene encoding major capsid protein
72. Identification and characterization of Marek's disease virus genes homologous to ICP27 and glycoprotein K of herpes simplex virus-1
73. Regulatory function of Marek's disease virus ICP27 gene product
74. The herpesviruses
75. The herpesviruses
76. Herpesviridae: Definition, provisional nomenclature, and taxonomy
77. The family herpesviridae: An update
78. Herpes simplex viruses and their replication
79. Molecular biology of the virus
80. DNA sequence and organization of genes in a 5.5kbp EcoRI fragment mapping in the short unique segment of Marek's disease virus (strain RB1B)
81. Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus
82. Marek's disease virus protein kinase gene identified within the short unique region of the viral genome is not essential for viral replication in cell culture and vaccine-induced immunity in chickens
83. Cell-specific antiviral activity of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) against Marek's disease herpesvirus and turkey herpes-virus
84. Nucleotide and predicted amino acid sequences of the Marek's disease virus and turkey herpesvirus thymidine kinase genes; comparison with thymidine kinase genes of other herpesviruses
85. Identification and sequence analysis of the homologues of herpes simplex virus type 1 glycoprotein H in Marek's disease virus and the herpesvirus of turkey
86. Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek's disease virus or turkey herpesvirus
87. Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex
88. Identification and characterization of a Marek's disease virus gene encoding DNA polymerase
89. Marek's disease virus gD expression is downregulated at the transcription level in cell culture
90. The genome of a very virulent Marek's disease virus
91. Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells
92. Deletion of the VP16 open reading frame of herpes simplex virus type 1
93. Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins
94. Synthesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins
95. Predicted nucleotide-binding properties of p 21 protein and its cancer-associated variant
96. Purification and characterization of infectious Marek's disease virus genomes using pulsed field electrophoresis
97. Molecular analysis of the glycoprotein C-negative phenotype of attenuated Marek's disease virus
98. Glycoprotein 300 is encoded by gene 28 of equine herpesvirus type 1: A new family of herpesvirus membrane proteins?
99. Antigenic and protein sequence homology between VP13/14, a herpes simplex virus type 1 tegument protein, and gp10, a glycoprotein of equine herpesvirus 1 and 4
100. Serological characteristics of a membrane glycoprotein gp82 of Marek's disease virus
101. Identification and characterization of glycoprotein H of MDV-1 GA strain
102. Cloning and sequence analysis of a Marek's disease virus origin binding protein (OBP) reveals strict conservation of structural motifs among OBPs of divergent alphaherpesviruses
103. Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-SB-1 MDV-transformed lymphoblastoid cells
104. A monoclonal antibody to ICP4 of MDV recognizing ICP4 of serotype 1 and 3 MDV strains
105. Nucleotide and predicted amino acid sequences of Marek's disease virus homologues of herpes simplex virus major tegument proteins
106. Varicella-zoster virus glycoprotein gpI/gpIV receptor: Expression, complex formation, and antigenicity within the vaccinia virus-T7-RNA polymerase transfection system
107. Identification and characterization of a Marek's disease virus gene homologous to glycoprotein L of herpes simplex virus
108. Mutational analysis of the proteolytic cleavage site of glycoprotein B (gB) of Marck's disease virus
109. ICP4 homologues of Marek's disease virus and herpesvirus of turkeys are larger than their alphaherpesvirus counterparts
110. Marek's disease virus type 1-specific phosphorylated proteins pp38 and pp24 with common amino acid termini are encoded from the opposite junction regions between the long unique and inverted repeat sequences of viral genome
111. Complex between glycoproteins gI and gp63 of pseudorabies virus: Its effect on virus replication